| pubmed-article:6320977 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6320977 | lifeskim:mentions | umls-concept:C0815000 | lld:lifeskim |
| pubmed-article:6320977 | lifeskim:mentions | umls-concept:C0279023 | lld:lifeskim |
| pubmed-article:6320977 | lifeskim:mentions | umls-concept:C0439596 | lld:lifeskim |
| pubmed-article:6320977 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:6320977 | pubmed:dateCreated | 1984-4-24 | lld:pubmed |
| pubmed-article:6320977 | pubmed:abstractText | Adenosine, 2-chloroadenosine and prostaglandin E1 which are known to increase cyclic AMP in neuroblastoma cells potentiated the acetylcholine-induced muscarinic hyperpolarization of the cells without changing the resting membrane potential. The potentiation caused by 2-chloroadenosine was further augmented by Ro 20-1724, a phosphodiesterase inhibitor. A direct intracellular pressure application of cyclic AMP potentiated the muscarinic hyperpolarization without changing the resting membrane potential. Morphine which inhibits adenylate cyclase antagonized 2-chloroadenosine-induced potentiation of the muscarinic hyperpolarization. These results suggest that changes in cyclic AMP level modulate the muscarinic response of neuroblastoma cells. | lld:pubmed |
| pubmed-article:6320977 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6320977 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6320977 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6320977 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:6320977 | pubmed:issn | 0006-8993 | lld:pubmed |
| pubmed-article:6320977 | pubmed:author | pubmed-author:NarahashiTT | lld:pubmed |
| pubmed-article:6320977 | pubmed:author | pubmed-author:TsunooAA | lld:pubmed |
| pubmed-article:6320977 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6320977 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:6320977 | pubmed:volume | 294 | lld:pubmed |
| pubmed-article:6320977 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6320977 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6320977 | pubmed:pagination | 123-6 | lld:pubmed |
| pubmed-article:6320977 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:meshHeading | pubmed-meshheading:6320977-... | lld:pubmed |
| pubmed-article:6320977 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6320977 | pubmed:articleTitle | Cyclic AMP-mediated potentiation of muscarinic hyperpolarization in neuroblastoma cells. | lld:pubmed |
| pubmed-article:6320977 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6320977 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:6320977 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6320977 | lld:pubmed |
